132 related articles for article (PubMed ID: 35752352)
1. CLDN6 inhibits breast cancer cell malignant behavior by suppressing ERK signaling.
Lu Y; Shao Y; Xie Y; Qu H; Qi D; Dong Y; Jin Q; Wang L; Wei J; Quan C
Cell Signal; 2022 Sep; 97():110393. PubMed ID: 35752352
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor β inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy.
Song P; Li Y; Dong Y; Liang Y; Qu H; Qi D; Lu Y; Jin X; Guo Y; Jia Y; Wang X; Xu W; Quan C
J Exp Clin Cancer Res; 2019 Aug; 38(1):354. PubMed ID: 31412908
[TBL] [Abstract][Full Text] [Related]
3. SMAD2 Inactivation Inhibits CLDN6 Methylation to Suppress Migration and Invasion of Breast Cancer Cells.
Lu Y; Wang L; Li H; Li Y; Ruan Y; Lin D; Yang M; Jin X; Guo Y; Zhang X; Quan C
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28867761
[TBL] [Abstract][Full Text] [Related]
4. The expression and the tumor suppressor role of CLDN6 in colon cancer.
Qu H; Wang M; Wang M; Liu Y; Quan C
Mol Cell Biochem; 2022 Dec; 477(12):2883-2893. PubMed ID: 35701678
[TBL] [Abstract][Full Text] [Related]
5. CLDN6 Suppresses c-MYC-Mediated Aerobic Glycolysis to Inhibit Proliferation by TAZ in Breast Cancer.
Qu H; Qi D; Wang X; Dong Y; Jin Q; Wei J; Quan C
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008557
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac.
Liu Y; Jin X; Li Y; Ruan Y; Lu Y; Yang M; Lin D; Song P; Guo Y; Zhao S; Dong B; Xie Y; Dang Q; Quan C
J Exp Clin Cancer Res; 2016 Jul; 35(1):120. PubMed ID: 27461117
[TBL] [Abstract][Full Text] [Related]
7. CLDN6 enhances chemoresistance to ADM via AF-6/ERKs pathway in TNBC cell line MDAMB231.
Yang M; Li Y; Ruan Y; Lu Y; Lin D; Xie Y; Dong B; Dang Q; Quan C
Mol Cell Biochem; 2018 Jun; 443(1-2):169-180. PubMed ID: 29159771
[TBL] [Abstract][Full Text] [Related]
8. CLDN6 inhibits breast cancer metastasis through WIP-dependent actin cytoskeleton-mediated autophagy.
Dong Y; Jin Q; Sun M; Qi D; Qu H; Wang X; Quan C
J Exp Clin Cancer Res; 2023 Mar; 42(1):68. PubMed ID: 36935496
[TBL] [Abstract][Full Text] [Related]
9. Effects of the Tight Junction Protein CLDN6 on Cell Migration and Invasion in High-Grade Meningioma.
Yang A; Yang X; Wang J; Wang X; Wu H; Fan L; Li H; Li J
World Neurosurg; 2021 Jul; 151():e208-e216. PubMed ID: 33862296
[TBL] [Abstract][Full Text] [Related]
10. CLDN6 promotes chemoresistance through GSTP1 in human breast cancer.
Yang M; Li Y; Shen X; Ruan Y; Lu Y; Jin X; Song P; Guo Y; Zhang X; Qu H; Shao Y; Quan C
J Exp Clin Cancer Res; 2017 Nov; 36(1):157. PubMed ID: 29116019
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of CLDN6 inhibits cell proliferation, migration, and invasion via regulating EGFR/AKT/mTOR signalling pathway in hepatocellular carcinoma.
Huang L; Zhao C; Sun K; Yang D; Yan L; Luo D; He J; Hu X; Wang R; Shen X; Xiao N; Zhong Z
Cell Biochem Funct; 2020 Jul; 38(5):541-548. PubMed ID: 32056244
[TBL] [Abstract][Full Text] [Related]
12. CLDN6 inhibits colorectal cancer proliferation dependent on restraining p53 ubiquitination via ZO-1/PTEN axis.
Dong Y; Xu W; Qi D; Qu H; Jin Q; Sun M; Wang X; Quan C
Cell Signal; 2023 Dec; 112():110930. PubMed ID: 37852424
[TBL] [Abstract][Full Text] [Related]
13. CLDN6 inhibited cellular biological function of nonsmall cell lung cancer cells through suppressing aerobic glycolysis via the RIP1/ASK1/JNK axis.
Guo H; Li J; Dong Y; Gao H; Wang P
J Biochem Mol Toxicol; 2024 Mar; 38(3):e23682. PubMed ID: 38462752
[TBL] [Abstract][Full Text] [Related]
14. Claudin-6 is a single prognostic marker and functions as a tumor-promoting gene in a subgroup of intestinal type gastric cancer.
Kohmoto T; Masuda K; Shoda K; Takahashi R; Ujiro S; Tange S; Ichikawa D; Otsuji E; Imoto I
Gastric Cancer; 2020 May; 23(3):403-417. PubMed ID: 31654186
[TBL] [Abstract][Full Text] [Related]
15. CLDN6: From Traditional Barrier Function to Emerging Roles in Cancers.
Qu H; Jin Q; Quan C
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948213
[TBL] [Abstract][Full Text] [Related]
16. SIX1 is upregulated in gastric cancer and regulates proliferation and invasion by targeting the ERK pathway and promoting epithelial-mesenchymal transition.
Xie Y; Jin P; Sun X; Jiao T; Zhang Y; Li Y; Sun M
Cell Biochem Funct; 2018 Dec; 36(8):413-419. PubMed ID: 30379332
[TBL] [Abstract][Full Text] [Related]
17. CLDN6-induced apoptosis via regulating ASK1-p38/JNK signaling in breast cancer MCF-7 cells.
Guo Y; Lin D; Zhang M; Zhang X; Li Y; Yang R; Lu Y; Jin X; Yang M; Wang M; Zhao S; Quan C
Int J Oncol; 2016 Jun; 48(6):2435-44. PubMed ID: 27035750
[TBL] [Abstract][Full Text] [Related]
18. A SUMOylation-dependent HIF-1α/CLDN6 negative feedback mitigates hypoxia-induced breast cancer metastasis.
Jia Y; Guo Y; Jin Q; Qu H; Qi D; Song P; Zhang X; Wang X; Xu W; Dong Y; Liang Y; Quan C
J Exp Clin Cancer Res; 2020 Feb; 39(1):42. PubMed ID: 32093760
[TBL] [Abstract][Full Text] [Related]
19. CLDN6 promotes tumor progression through the YAP1-snail1 axis in gastric cancer.
Yu S; Zhang Y; Li Q; Zhang Z; Zhao G; Xu J
Cell Death Dis; 2019 Dec; 10(12):949. PubMed ID: 31827075
[TBL] [Abstract][Full Text] [Related]
20. Cisatracurium inhibits the proliferation, migration and invasion of breast cancer cells by regulating the expression of miR-3174.
Yang X; Ma W
Cell Mol Biol (Noisy-le-grand); 2020 Sep; 66(6):1-7. PubMed ID: 33040777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
